|
1
|
Caffeinated energy drinks--a growing problem.
|
Drug Alcohol Depend
|
2008
|
4.98
|
|
2
|
Buprenorphine: how to use it right.
|
Drug Alcohol Depend
|
2003
|
2.35
|
|
3
|
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations.
|
Pain
|
2013
|
1.89
|
|
4
|
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.
|
Drug Alcohol Depend
|
2009
|
1.56
|
|
5
|
A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.
|
J Addict Med
|
2013
|
1.47
|
|
6
|
Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants.
|
J Clin Psychiatry
|
2016
|
1.39
|
|
7
|
A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
|
Anal Biochem
|
2002
|
1.32
|
|
8
|
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
|
Drug Alcohol Depend
|
2007
|
1.28
|
|
9
|
Characteristics of older opioid maintenance patients.
|
J Subst Abuse Treat
|
2005
|
1.22
|
|
10
|
Decreased frontal white-matter volume in chronic substance abuse.
|
Int J Neuropsychopharmacol
|
2005
|
1.20
|
|
11
|
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
|
J Subst Abuse Treat
|
2006
|
1.17
|
|
12
|
Changing profile of abused substances by older persons entering treatment.
|
J Nerv Ment Dis
|
2008
|
1.16
|
|
13
|
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
|
Exp Clin Psychopharmacol
|
2005
|
1.14
|
|
14
|
Treatment of patients with substance use disorders, second edition. American Psychiatric Association.
|
Am J Psychiatry
|
2007
|
1.14
|
|
15
|
The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.
|
Drug Alcohol Depend
|
2011
|
1.14
|
|
16
|
Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients.
|
J Gen Intern Med
|
2002
|
1.08
|
|
17
|
Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
|
Psychopharmacology (Berl)
|
2007
|
1.06
|
|
18
|
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
|
Alcohol Clin Exp Res
|
2012
|
1.05
|
|
19
|
Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance abuse treatment center.
|
J Subst Abuse Treat
|
2010
|
0.98
|
|
20
|
Service use and barriers to mental health care among adults with major depression and comorbid substance dependence.
|
Psychiatr Serv
|
2013
|
0.97
|
|
21
|
Voucher-based reinforcement of opiate abstinence during methadone detoxification.
|
Drug Alcohol Depend
|
2002
|
0.97
|
|
22
|
Discriminative stimulus effects of tramadol in humans.
|
J Pharmacol Exp Ther
|
2011
|
0.97
|
|
23
|
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
|
Psychopharmacology (Berl)
|
2006
|
0.95
|
|
24
|
Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
|
Addiction
|
2003
|
0.94
|
|
25
|
Treatment of patients with substance use disorders, second edition. American Psychiatic Association.
|
Am J Psychiatry
|
2006
|
0.93
|
|
26
|
Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.
|
Am J Addict
|
2009
|
0.91
|
|
27
|
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report.
|
Drug Alcohol Depend
|
2006
|
0.91
|
|
28
|
Physical dependence potential of daily tramadol dosing in humans.
|
Psychopharmacology (Berl)
|
2010
|
0.90
|
|
29
|
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.
|
J Opioid Manag
|
2012
|
0.90
|
|
30
|
A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.
|
J Subst Abuse Treat
|
2011
|
0.89
|
|
31
|
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.
|
Exp Clin Psychopharmacol
|
2006
|
0.87
|
|
32
|
Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.
|
Drug Alcohol Depend
|
2010
|
0.87
|
|
33
|
A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
|
Drug Alcohol Depend
|
2004
|
0.85
|
|
34
|
Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users.
|
J Appl Behav Anal
|
2014
|
0.84
|
|
35
|
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers.
|
Psychopharmacology (Berl)
|
2010
|
0.84
|
|
36
|
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.
|
Psychopharmacology (Berl)
|
2010
|
0.83
|
|
37
|
Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting.
|
J Subst Abuse Treat
|
2007
|
0.83
|
|
38
|
Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
|
Am J Psychiatry
|
2007
|
0.83
|
|
39
|
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2006
|
0.83
|
|
40
|
An fMRI investigation of cerebellar function during verbal working memory in methadone maintenance patients.
|
Cerebellum
|
2012
|
0.82
|
|
41
|
Increased blood pressure after abrupt cessation of daily cannabis use.
|
J Addict Med
|
2011
|
0.82
|
|
42
|
A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.
|
J Pharmacol Exp Ther
|
2013
|
0.81
|
|
43
|
Pretreatment alcohol drinking goals are associated with treatment outcomes.
|
Alcohol Clin Exp Res
|
2013
|
0.80
|
|
44
|
Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.
|
J Addict Med
|
2013
|
0.79
|
|
45
|
Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial.
|
Am J Addict
|
2005
|
0.78
|
|
46
|
The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.
|
Am J Drug Alcohol Abuse
|
2010
|
0.78
|
|
47
|
Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes.
|
Pain
|
2016
|
0.77
|
|
48
|
Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine.
|
Exp Clin Psychopharmacol
|
2010
|
0.77
|
|
49
|
Experimentally-induced spontaneous opiate withdrawal: relationship to cigarette craving and expired air carbon monoxide.
|
Am J Addict
|
2007
|
0.77
|
|
50
|
Screening for Mood Disorder in Pregnant Substance-dependent Patients.
|
Addict Disord Their Treat
|
2009
|
0.77
|
|
51
|
Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence.
|
Drug Alcohol Depend
|
2012
|
0.76
|
|
52
|
Opioid abusers' ability to differentiate an opioid from placebo in laboratory challenge testing.
|
Drug Alcohol Depend
|
2013
|
0.75
|
|
53
|
The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.
|
Clin J Pain
|
2014
|
0.75
|
|
54
|
Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers.
|
Am J Drug Alcohol Abuse
|
2015
|
0.75
|
|
55
|
Behavioural health interventions in the Johns Hopkins Community Health Partnership: integrated care as a component of health systems transformation.
|
Int Rev Psychiatry
|
2014
|
0.75
|
|
56
|
Strain Interview (11/17/15)—Diann Gaalema.
|
Drug Alcohol Depend
|
2016
|
0.75
|
|
57
|
Drug and Alcohol Dependence Fellowship.
|
Drug Alcohol Depend
|
2015
|
0.75
|
|
58
|
Introduction to CPDD abstracts from the 2016 conference.
|
Drug Alcohol Depend
|
2017
|
0.75
|
|
59
|
[Brazilian guideline for the treatment of patients with opioids dependence syndrome].
|
Rev Bras Psiquiatr
|
2005
|
0.75
|
|
60
|
Changes at drug and alcohol dependence.
|
Drug Alcohol Depend
|
2010
|
0.75
|